DENGUE FEVER: MARKET GROWTH, EPIDEMIOLOGY, AND FUTURE PROJECTIONS (2024-2032)

Dengue Fever: Market Growth, Epidemiology, and Future Projections (2024-2032)

Dengue Fever: Market Growth, Epidemiology, and Future Projections (2024-2032)

Blog Article

Dengue fever, a mosquito-borne viral infection, continues to be a critical global health issue. With over half the global population at risk, its prevalence is fueled by urbanization, climate change, and ineffective mosquito control. These challenges emphasize the urgent demand for effective treatments and vaccines, driving innovation in the market.

Market Insights
The dengue fever market is poised for significant growth by 2032, driven by rising disease incidence and advances in medical research. Current treatments rely on supportive care for symptoms such as fever, headaches, and joint pain due to the absence of specific antiviral therapies. However, ongoing R&D in antiviral drugs and vaccine development aims to address this unmet need.

Key growth drivers include increased investment in vaccine development. Dengvaxia, the first FDA-approved dengue vaccine, has set a foundation for progress. Promising candidates like TAK-003 by Takeda Pharmaceuticals, now in late-stage trials, are expected to enhance prevention, particularly against severe cases.

Epidemiology
Dengue fever is endemic in over 100 countries, with tropical and subtropical regions heavily impacted. WHO estimates 390 million annual infections, with 96 million symptomatic cases. Asia, Latin America, and Africa experience the highest burden, with urban centers as transmission hotspots. Strengthened diagnostic, surveillance, and vector control measures remain essential.

Market Forecast
The dengue fever market is expected to grow rapidly from 2024 to 2032, driven by improved awareness, diagnostics, and vaccine introductions. The Asia-Pacific region will likely dominate due to high disease prevalence and supportive vaccine policies.

Conclusion
The dengue fever market is set for robust expansion through innovation, increased awareness, and investments in vaccines. Advancements in prevention and treatment strategies aim to reduce the global disease burden significantly.

Recent DelveInsight Reports


About DelveInsight
DelveInsight specializes in life sciences and healthcare market research, delivering actionable insights to empower pharmaceutical, biotech, and medical device companies.

Contact Information
Kanishk
Email: kkumar@delveinsight.com

Report this page